Search

A recent study conducted by researchers at the KTH Royal Institute of Technology has shed light on the mechanisms of hormone replacement therapy (HRT). The study focused on the r1 GABAA receptor, which is a potential target for the treatment of visual, sleep, and cognitive disorders. The researchers used cryo-EM structures, electrophysiology, and molecular dynamics simulations to investigate the inhibitory mechanisms of two neuroactive steroids, b-estradiol and pregnenolone sulfate, on the r1 GABAA receptor. The findings revealed contrasting mechanisms of inhibition by these steroids, which could have implications for subtype-specific gating and the design of pharmacological treatments. [Extracted from the article]

Researchers from Yunnan University in Kunming, China have conducted a study on the use of biochar composite photocatalysts for removing endocrine disruptors (EDCs). The researchers found that the composite photocatalysts were highly efficient in degrading 17 alpha-ethinylestradiol (EE2) and 17 beta-estradiol (E2) when used in conjunction with persulfate synergy. The study also showed that biochar enhances the catalytic activity of the photocatalytic system through various mechanisms. The research fills a gap in the understanding of the mechanism of action of biochar and provides a green catalyst with excellent photocatalytic efficiency and detoxification properties. [Extracted from the article]

A study conducted at the University of Wisconsin - Milwaukee explores the role of astrocytic glutamate transport in the memory-enhancing effects of 17b-estradiol in ovariectomized mice. The researchers found that the infusion of 17b-estradiol into the dorsal hippocampus of mice enhances memory consolidation, which depends on the rapid phosphorylation of extracellular signal-regulated kinase (ERK) and Akt. The study suggests that astrocytic function in the dorsal hippocampus is necessary for memory formation and is regulated by 17b-estradiol, highlighting the essential role of astrocytic glutamate transport in the memory-enhancing effects of 17b-estradiol. [Extracted from the article]

Researchers at the University of Turku in Finland have conducted a study on the direct electrochemical co-detection of estradiol (E2) and dopamine (DA), two important hormones that impact women's health and neurotransmitter systems. The study focused on the use of Ti-Ni-CNF electrodes with carbon nanofibers (CNFs) grown for different lengths of time. The longer growth time resulted in increased CNF length and electroactive surface area, leading to improved sensor performance. The findings of this study could contribute to the development of more accurate and accessible continuous hormone measurements. [Extracted from the article]

A study conducted at Mansoura University in Egypt explored the effects of lycopene on ovarian damage caused by repeated cycles of superovulation. Superovulation is an important step in assisted reproductive technology that involves the administration of gonadotrophins. The study found that mice treated with lycopene showed increased numbers of healthy follicles, decreased levels of atretic follicles, and improved expression of antioxidant- and apoptosis-related genes in the ovaries. Additionally, lycopene administration resulted in elevated levels of reproductive hormones, such as estradiol, progesterone, and inhibin-B. These findings suggest that lycopene may have a significant role in reducing ovarian damage and improving the outcomes of in vitro embryo production. [Extracted from the article]

A recent study conducted at Suzuka University of Medical Science in Mie, Japan, explored the association between weight gain and sex-related differences in cancer patients undergoing 5-fluorouracil (5-FU) administration. The researchers found that female mice receiving 5-FU experienced weight gain and increased food intake. They also observed changes in hormone levels and receptor expression that may contribute to weight gain in female patients undergoing certain cancer therapies. These findings suggest the presence of sex differences in weight gain during cancer treatment and highlight the need for further research in this area. [Extracted from the article]

A recent study conducted by researchers at Texas Tech University Health Sciences Center examined the accuracy and sensitivity of urinary hormone levels in fertility tracking apps and devices. The study found that serum hormones, specifically estradiol (E2) and progesterone (P), may be better biomarkers for tracking ovulatory cycle events compared to urinary hormone levels. The researchers used mathematical tools to analyze hormone levels and found that serum E2 and (E2, P) were effective in signaling the start of the fertile window and the ovulation/luteal transition interval. These findings have implications for the development of future fertility tracking technology. [Extracted from the article]

A recent study conducted by researchers at Kongju National University investigated the effects of prolonged inhalation of nature-derived odors on menopausal women. The study involved 26 women who inhaled fir essential oil for a week. The results showed that prolonged inhalation of the oil led to increased estradiol concentration, decreased blood pressure, relief of menopausal symptoms, reduced anxiety levels, improved sleep quality, and mood states. This research suggests that inhaling nature-derived odors may induce physiological and psychological relaxation in menopausal women. [Extracted from the article]

A recent study conducted by researchers from Texas Tech University Health Sciences Center explores the role of the steroidogenic acute regulatory protein (StAR) in breast cancer. The study found that StAR, which is involved in steroid biosynthesis, is acetylated in breast cancer cells and influences the synthesis of 17b-estradiol (E2), a hormone that plays a critical role in breast tumorigenesis. The researchers discovered specific lysine residues that are acetylated in malignant and non-malignant breast cells, and manipulating these acetylation states affected E2 levels. These findings provide new insights into the regulation of E2 in hormone-sensitive breast cancer and suggest that StAR could be a potential therapeutic target. [Extracted from the article]

A new report from researchers at Shahid Beheshti University of Medical Sciences in Tehran, Iran explores the relationship between estradiol levels and the clinical characteristics of postmenopausal women with endometrial malignancies and abnormal uterine bleeding. The study, conducted in 2023 on 54 patients, found that there is a correlation between estradiol levels and high endometrial thickness and a family history of uterine malignancy in women with endometrial malignancy. The most common type of pathology in both groups was grade 1 endometrioid adenocarcinoma. This research provides valuable insights into the role of endocrine hormones in endometrial malignancies during menopause. [Extracted from the article]

A recent study conducted by Yokohama University of Pharmacy in Japan explored the effects of hormone replacement therapy on the behavior of young ovariectomized mice. The researchers found that ovariectomy surgery at a young age led to decreased locomotor activity and a preference for novel mice in social tests. However, the administration of a G protein-coupled receptor 30 agonist ameliorated these effects. The study suggests that G protein-coupled receptor 30-mediated regulation of serotonin synthesis may play a role in the behavioral changes caused by decreased estradiol levels during childhood. [Extracted from the article]

A recent study conducted in Kagawa, Japan, explored the self-recovery ability of dermal papilla cells (DPCs) and its potential role in hair growth. The researchers subjected DPCs to various growth-inhibiting stressors and observed changes in cell proliferation capacity and gene expression. They identified two proteins, Chitinase 3-like 1 (CHI3L1) and C-X-C motif chemokine 5 (CXCL5), that were found to promote outer root sheath cell (ORSC) proliferation and hair follicle growth. The study suggests that CHI3L1 and CXCL5 secreted by recovery-state DPCs may play a role in promoting hair growth. [Extracted from the article]

Researchers at Universidad Catolica del Norte in Chile have developed a novel electrochemical sensor that can rapidly and simultaneously detect levels of serotonin and 17b-estradiol, two key analytes implicated in premenstrual dysphoric disorder (PMDD). The sensor demonstrated high sensitivity and stability, as well as selectivity against common interferents found in biological fluids. It was successfully used to measure serotonin and 17b-estradiol in human serum and urine. The researchers believe that this sensor has the potential to contribute to the accurate diagnosis and treatment of PMDD, and may improve the quality of life for women suffering from hormonal malfunctions. [Extracted from the article]

A recent study conducted by researchers at the University of Kentucky explores the differences in outcomes between males and females after traumatic brain injury (TBI). The study suggests that estrogen may play a role in promoting mitochondrial protection following TBI. The researchers found that treatment with 17b-estradiol (E2) improved mitochondrial function in mice after experimental TBI. These findings highlight the importance of studying mitochondrial dysfunction in both sexes after TBI and suggest a potential neuroprotective mechanism for E2 in attenuating mitochondrial dysfunction. [Extracted from the article]

Researchers from Ben-Gurion University of the Negev in Israel have conducted a study on the protective effects of carotenoids, polyphenols, and estradiol on skin cells. The study found that these compounds can reverse the damage caused by mitochondrial dysfunction, which is associated with skin aging. The protective effects are attributed to the activation of the antioxidant response element (ARE/Nrf2) transcription system, which upregulates antioxidant proteins. This research suggests that phytonutrients and estradiol may delay skin cell senescence and improve skin health. [Extracted from the article]

A recent study conducted by researchers at the University of Melbourne in Australia has found that the electrophysiological properties of the hearts of men and women are different. These differences are influenced by the actions of circulating estrogens and androgens on the cardiomyocytes. The study compared the electrophysiological properties of male and female atria and assessed their responses to acute sex steroid exposure. The findings suggest that these differences may play a role in determining atrial arrhythmia vulnerability, particularly as systemic sex steroid levels change and intra-cardiac estrogen synthesis capacity increases with aging. [Extracted from the article]

A recent research study conducted at Stockholm University in Sweden investigated the effects of persistent organic pollutants (POPs) on testosterone and estrogen synthesis at concentrations relevant to human exposure. The study used a human adrenocortical cell line called H295R and screened 24 POPs for their effects on viability and hormone synthesis. The results showed that some POPs can interfere with endocrine signaling at concentrations found in human blood, highlighting the need for further investigation into the toxicological mechanisms of POPs and their mixtures. The research has been peer-reviewed and published in the journal Cell Biology and Toxicology. [Extracted from the article]

New research from Harbin Medical University in China has developed a new method for detecting beta-estradiol, an active hormone in steroids that plays a vital role in human reproductive and non-reproductive systems. The researchers used copper ferrite nanoparticles and laser-induced graphene to functionalize screen-printed carbon electrodes, which demonstrated a synergistic effect on the catalysis of beta-estradiol. The sensor showed good selectivity, reproducibility, stability, and anti-interference performance, making it potentially valuable for detecting female reproductive-related diseases. The study was published in the Chemical Engineering Journal and was supported by the National Natural Science Foundation of China and the Scientific Research Fund of Heilongjiang Provincial Scientific Research Institutes. [Extracted from the article]

The article from Stellenbosch University explores how chronic stress affects heart function in rats subjected to ischemia, with a focus on sex-dependent differences. The research underscores the importance of considering sex as a biological variable in studies on stress-related heart conditions, highlighting that females may be more vulnerable to ischemic damage due to stress-induced changes.

A study conducted at the National University in Rosario, Argentina, explores the effects of tauroursodeoxycholate (TUDC) on cholestasis induced by estradiol 178-d-glucuronide (E 2 17G). Cholestasis is characterized by the impaired function and localization of canalicular transporters Bsep and Mrp2. The study found that TUDC can prevent the endocytosis of these transporters by inhibiting cPKC and PI3K/Akt activation. TUDC restores the function and localization of Bsep and Mrp2, providing a potential treatment option for cholestasis. [Extracted from the article]

A recent report from Zhejiang University in China discusses research on apoptosis, specifically focusing on the protective effects of Ganoderma lucidum spores (GLS) on thymic atrophy and T cell development. The study used a mice model to evaluate the impact of GLS on thymic damage caused by estradiol benzoate (EB). The researchers found that GLS effectively mitigated EB-induced thymic damage by reducing apoptotic thymic epithelial cells (TECs) and enhancing the output of CD4+ T cells. Additionally, GLS promoted T cell receptor rearrangement and facilitated the development of double-positive (DP) to invariant natural killer T (iNKT) cells. The study suggests that GLS has potential as a T-cell regeneration inducer. [Extracted from the article]

A recent study conducted by researchers at the University of Sao Paulo in Brazil explores the relationship between serotonin neurotransmission, hormonal variation, and conditioned fear in female rats. The study found that high-anxiety female rats had higher levels of estradiol and progesterone, which contributed to increased startle responses. In contrast, female rats experienced a decrease in hormone levels during the Diestrus phase, which prevented them from displaying heightened startle responses. The researchers concluded that serotonin neurotransmission, in conjunction with progesterone and estrogen, reduces startle potentiation by activating the serotonin-1A receptor subtype. This research provides valuable insights into the role of hormones in anxiety disorders. [Extracted from the article]

A recent study conducted by researchers at the University of Quebec Trois-Rivieres has discovered a new hybrid molecule that shows potential as an anticancer agent. The molecule, made up of estradiol and testosterone, was designed to interact with both estrogen and androgen receptors found in hormone-dependent cancer cells. The researchers found that the molecule was effective against hormone-dependent breast cancer cells, but had limited effects on prostate cancer cells. However, it showed activity against colon and skin cancer cells. Further research is needed to explore the potential of this new type of hybrid molecule. [Extracted from the article]

A recent report from the Icahn School of Medicine at Mount Sinai discusses the potential interference of the drug abemaciclib with the estradiol Abbott Alinity chemiluminescent microparticle immunoassay (CMIA) commonly used to monitor estradiol levels in premenopausal women with hormone receptor-positive breast cancer. The study found that abemaciclib may lead to inaccurate estradiol level measurements using CMIA, and suggests that liquid chromatography-mass spectrometry (LC-MS/MS) should be used instead. The researchers recommend using LC-MS/MS when monitoring estradiol levels in patients receiving abemaciclib alongside ovarian function suppression (OFS). This information is important for healthcare providers to ensure accurate monitoring and appropriate treatment modifications. [Extracted from the article]

A recent report from the University of Southern California (USC) provides an overview of estrogen metabolism in women. The research highlights the importance of understanding the metabolism of both endogenous and exogenous estrogens in order to determine therapeutic estrogen levels. The study identifies four principal endogenous estrogens and discusses their extensive metabolism through phase I and phase II reactions. The researchers also note the need for further research to better understand the impact of estrogen metabolism on dosing and the regulation of endogenous estrogens. This research has been peer-reviewed and is available in the Journal of Steroid Biochemistry and Molecular Biology. [Extracted from the article]

A study conducted at Fudan University Shanghai Cancer Center explores two key questions in assessing the menopausal status of female breast cancer patients. The study emphasizes the importance of endocrine therapy in hormone receptor-positive breast cancer and its close relationship to the patient's menopausal status. The researchers recommend considering factors such as the impact of chemotherapy on menopausal status and the complexity of hormone levels around menopause when determining whether patients under ovarian function suppression therapy have reached physiological menopause. In challenging cases, a comprehensive evaluation can be conducted by incorporating markers such as anti-Mullerian hormone, inhibin B, and androgen. [Extracted from the article]

The article focuses on evaluating the tolerance of 17α-estradiol dosing in male common marmosets to understand its effects including the pilot study's design and methods, dosing tolerability outcomes, and implications for future geriatric and gerontology research.

The article focuses on the approval of the Corina Intrauterine Drug-Eluting System in China for treating moderate-to-severe intrauterine adhesions (IUA). Topics include the device's efficacy in preventing re-adhesion post-surgery, its innovative drug-delivery mechanism using estradiol, and the high incidence of IUA in China following intrauterine interventions.

The article reports new findings from Guangzhou Medical University on inflammatory bowel disease (IBD). Topics include the role of 17β-estradiol in promoting myeloid-derived suppressor cells (MDSCs) and alleviating IBD symptoms, the impact of estrogen on the progression of IBD in mouse models, and the molecular mechanisms involving STAT3 and NF-κB activation in this process.

A patent application by inventors from Shimadzu Corporation has been made available online for a method of analyzing steroid compounds in a sample using liquid chromatograph mass spectrometry (LC/MS). The method involves dividing the sample into multiple liquid fractions, treating each fraction differently, mixing the fractions together, and analyzing the mixed sample solution with a liquid chromatograph mass spectrometer. This method aims to shorten the analysis time for steroid compounds in a sample. The inventors propose using a solid-phase extraction column to divide the sample into liquid fractions and suggest the use of an organic acid or organic acid salt in the solvent of the mixed sample solution. [Extracted from the article]

This document provides information about a clinical trial that is currently recruiting participants. The trial aims to study the effects of estrogen replacement therapy in women with Turner syndrome (TS), a genetic disorder that affects females. The trial is open to women between the ages of 18 and 50 who have already been receiving estrogen treatment. The study will exclude individuals with certain medical conditions or contraindications to estrogen therapy. The trial is being conducted in Denmark by the University of Aarhus. [Extracted from the article]

A clinical trial, NCT06546397, is currently recruiting participants to study the effects of combined estrogen and progesterone therapy on endometrial repair and ovarian function recovery after induced abortion. The trial aims to address potential risks associated with repeated induced abortions, such as uterine damage and infertility. The study will evaluate the thickness of the endometrium, cycle normalization rate, duration of vaginal bleeding after surgery, and menstrual flow volume as primary and secondary outcome measures. The study is being conducted in China and is expected to be completed by December 2025. [Extracted from the article]

A recent report from Chonbuk National University Hospital in South Korea discusses research on polycystic ovary syndrome (PCOS). The study analyzed the medication use patterns and safety of drugs among patients diagnosed with PCOS. The research found that the most prescribed medications for PCOS were medroxyprogesterone acetate (MPA) and ethinyl estradiol with drospirenone. Adverse drug reactions occurred in 7.1% of patients, with 4.8% being adolescents and 9.3% being adults. The study also noted that some patients changed prescriptions or discontinued medications. [Extracted from the article]

A recent study conducted by researchers at Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) in Germany focused on the development and evaluation of estradiol derivatives for the positron emission tomography (PET) imaging of estrogen receptor-positive (ER+) breast cancer. The current FDA-approved imaging probe for ER+ breast cancer, 16a-[18F]fluoroestradiol (FES), has limitations due to high retention in the liver. The study aimed to address this issue by developing estradiol derivatives with different lipophilicity. The researchers found that one derivative, 18F-TA-Glyco-EE, showed promising results with high uptake in ER+ tumor cells and rapid clearance from non-target tissues. This derivative may serve as an alternative to FES for PET imaging of breast cancer. [Extracted from the article]

A study conducted at Beirut Arab University explored the impact of Gundelia tournefortii extract on polycystic ovarian syndrome (PCOS). PCOS is a common endocrine disorder that affects women and increases the risk of infertility, cardiovascular diseases, and hypertension. The study used female mice with induced PCOS and treated them with the extract. The results showed that the extract reduced follicular cysts in the ovaries, decreased testosterone and estradiol levels, normalized markers of oxidative stress, and restored the expression of certain enzymes. The researchers concluded that Gundelia tournefortii extract could be a potential therapeutic agent for PCOS. [Extracted from the article]

The article discusses a new study from Islamic Azad University exploring the effects of high-intensity interval training and yoga on serum estradiol levels and sexual function in postpartum women. Topics include the significance of sexual health in marital relationships, the impact of postpartum changes on sexual function, and the effectiveness of specific physical training programs in improving sexual outcomes.

A study conducted by researchers at Pusan National University School of Medicine in South Korea examined the effects of hormone replacement therapy (HT) on cardiovascular and metabolic parameters in a mouse model of primary ovarian insufficiency (POI). The study found that on-time, continuous estradiol treatment immediately after estrogen deprivation significantly reduced metabolic and cardiovascular risks in the mouse models, as well as decreased levels of pro-inflammatory cytokines. The findings suggest that HT may have potential benefits for young, pre-menarche females with POI. Further research is needed to explore these effects in humans. [Extracted from the article]

A study conducted in Urumqi, China explored the impact of biomimetic electrical stimulation combined with Femoston (estradiol and dydrogesterone tablets) on pregnancy rate and endometrium characteristics in patients with infertility and a thin endometrium. The study enrolled 120 patients who were divided into two groups: one receiving Femoston alone and the other receiving Femoston combined with biomimetic electrical stimulation. The results showed that the endometrium of patients in the electrotherapy group was thicker and had a higher percentage of patients with favorable endometrial types compared to the Femoston group. However, there was no significant improvement in pregnancy rates. The researchers suggest that further confirmation is needed. [Extracted from the article]

A recent study conducted by the Medical University of Silesia in Poland examined the impact of hypothyroidism during pregnancy on the reproductive development of infant girls. The study found that non-substituted or inadequately treated hypothyroidism during pregnancy may impair the course of minipuberty in female offspring. The researchers measured salivary concentrations of hormones and urine levels of gonadotropins in three groups of infant girls: those born to women with hypothyroidism, those born to women with adequately substituted hypothyroidism, and those born to healthy women. The study concluded that there were significant differences in hormone levels and the size of reproductive structures between the groups. [Extracted from the article]

A recent study conducted by researchers at Renmin Hospital of Wuhan University in China explored the efficacy of a combination treatment for preventing ovarian hyperstimulation syndrome (OHSS) in high-risk women. The treatment involved a cocktail of GnRH-antagonist, letrozole, and mifepristone. The study, which included 170 women, found that the combination treatment significantly reduced the incidence of moderate and severe OHSS compared to a group that received only mifepristone. The treatment also resulted in decreased serum estradiol levels, ovarian diameter, and luteal phase. However, there was no significant difference in cumulative live birth rates between the two groups. [Extracted from the article]

A study conducted by researchers at the Indian Institute of Technology Roorkee investigated the degradation of four emerging contaminants in water and sediment systems. The compounds studied were estrone, progesterone, sulfamethoxazole, and trimethoprim. The research found that bio-photodegradation was the most effective method of removing these contaminants. The study also identified transformation products in the Yamuna River, confirming the presence of degradation pathways in the environment. The research was supported by the Department of Science & Technology in India and has been peer-reviewed. [Extracted from the article]

A recent study conducted by researchers from the National Autonomous University of Mexico (UNAM) examined the role of sex steroids in colorectal cancer. The study found that men have a higher incidence of colorectal cancer compared to women, and there is a disturbance in the levels of sex steroids in patients with this disease. In animal models, males also exhibited greater tumor growth than females. The researchers used a chemical method to induce colorectal tumors in mice and found that males developed a greater number of tumors with larger sizes compared to females. The study also revealed that estradiol decreased the proliferation of colon cancer cells in vitro, while testosterone increased proliferation. Dihydrotestosterone did not have an influence on proliferation. These findings suggest a sexual dimorphism in colorectal cancer and highlight the potential role of sex steroids in the development and progression of the disease. [Extracted from the article]

A recent report from Leipzig University Medical Center discusses the role of sex hormones in regulating lipid metabolism genes in primary human hepatocytes. The study found that there are differences in gene expression levels and responsiveness to sex hormones between male and female hepatocytes. These findings suggest that considering cellular sex is important when studying the mechanisms of metabolic dysfunction-associated steatotic liver disease (MASLD). Further research in this area could help to better understand the hormonal and genetic causes of sex differences in MASLD. [Extracted from the article]